Catalogs >
Integra LifeSciences >
Integra ® Bilayer Wound Matrix

Integra ® Bilayer Wound Matrix
6Pages

Catalog excerpts

Integra® Bilayer Wound Matrix CASE STUDIES

Case Study 1 Type of Wound: Venous Stasis Ulcer Patient: 62 year old female Duration of condition: 6 years A 62 year old female with HIV and a chief complaint of a venous stasis ulceration was treated for approximately 6 years with compression dressings, various wound dressings, and skin grafts (Figure 1-1). She was interested in attempting a new wound matrix which would potentially help her heal the chronic ulceration. Following vein ablation surgery, the patient’s venous stasis ulcer was debrided down to the superficial fascia level. At this point, the Integra Bilayer Wound Matrix was cut...

Open the catalog to page 2

Case Study 2 Type of Wound: Chronic Wound, Vasculitis Patient: 62 year old female A 62 year old female was referred to the wound care center with ulceration to both of her feet and anterior ankles. The wounds were previously treated with operative debridements, followed by negative pressure wound therapy. Initial treatment included debridement of the wounds with incisional skin biopsy, followed by application of a split-thickness skin graft. The right foot healed uneventfully, while the left skin graft did not take. The pathology report suggested the etiology to be vasculitis (unidentified...

Open the catalog to page 3

Case Study 3 Type of Wound: Diabetic Foot Ulcer Patient: 67 year old male A 67 year old male with a history of Type II diabetes and HIV, with a history of abscess and osteomyelitis of the left 5th metatarsal head, with subsequent resection of the metatarsal head. Approximately two years later he developed a contracted 4th hammertoe with retrograde plantar flexion of the 4th metatarsal (Figure 3-1). A grade II ulcer developed as a result of the increased pressure sub4th metatarsal head (Figure 3-2). Local care and off-loading with orthotics did not resolve the problem. The ulcer was not...

Open the catalog to page 4

Description Integra® Bilayer Wound Matrix is an advanced wound care device comprised of a porous matrix of cross-linked bovine tendon collagen and glycosaminoglycan and a semi-permeable polysiloxane (silicone) layer. Indications Integra Bilayer Wound Matrix is indicated for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, and skin...

Open the catalog to page 5

• Intega Bilayer Wound Matrix is supplied sterile, in single use, double peel packages containing phosphate buffer. • Store flat at room temperature. • For technical questions or reimbursement issues, please call 800-654-2873 or 609-275-0500 • For further technical training, please contact your local Extremity Reconstructive Sales Specialist. • For more information, please visit www.ilstraining.com Reference Size Units/Case In a study of 107 patients having 158 documented individual ulcers, 92% of patients healed completely by Integra alone or with small subsidiary flaps (excluding...

Open the catalog to page 6

Integra ® Bilayer Wound Matrix 6Pages

Catalog excerpts

All Integra LifeSciences catalogs and technical brochures

Integra ® Bilayer Wound Matrix
6Pages